MCST(300355)2017-10-25 16:00Financial Performance - Net profit attributable to shareholders rose by 172.99% to CNY 321.44 million for the current period[8] - Operating revenue for the current period reached CNY 1.90 billion, a 135.92% increase year-on-year[8] - Basic earnings per share increased by 150.00% to CNY 0.200 for the current period[8] - The weighted average return on equity improved to 10.18%, up from 4.98% in the previous year[8] - The company reported a net profit of CNY 717.99 million for the year-to-date, reflecting a 198.71% increase compared to the same period last year[8] - The company's net profit attributable to the parent company was 71,799.54 million RMB, a growth of 198.71% year-on-year, driven by an increase in orders and steady business progress[25] - Net profit for Q3 2017 was CNY 332,120,828.46, representing a 153.4% increase from CNY 131,109,967.18 in Q3 2016[46] - Net profit for the period was CNY 743,797,366.98, up from CNY 255,235,076.60, indicating a growth of approximately 191.5%[51] Asset and Liability Changes - Total assets increased by 63.25% to CNY 11.47 billion compared to the end of the previous year[8] - The company's total liabilities increased to CNY 7.69 billion, up from CNY 3.95 billion, representing an increase of about 94.5%[41] - Current assets totaled CNY 9.91 billion, a significant rise from CNY 5.59 billion, indicating an increase of approximately 77.5%[39] - The ending balance of accounts receivable increased by 101.07% to CNY 681,091.26 million, driven by business growth and progress in PPP projects[20] - The ending balance of accounts payable increased by 81.41% to CNY 237,735.72 million, resulting from increased project output and corresponding payable amounts[21] - Long-term borrowings at the end of the period amounted to 71,830.54 million RMB, up 224.33% from the beginning of the period, mainly due to increased loans from financial institutions[24] - Total liabilities as of Q3 2017 were CNY 6,447,729,878.35, up from CNY 2,756,004,497.89 in the previous year, reflecting a growth of 134.5%[43] Cash Flow and Financing Activities - Net cash flow from operating activities showed a decline of 152.50%, totaling CNY -1.37 billion year-to-date[8] - Cash received from operating activities increased by 211.55% to 9,985.28 million RMB, mainly from government subsidies and other receivables[25] - The company reported a net cash flow from operating activities of -CNY 1,365,531,090.00, worsening from -CNY 540,813,985.84 in the previous period[54] - Total cash inflow from financing activities reached 2,131,180,855.58 yuan, an increase from 1,489,299,998.20 yuan in the previous period[56] - The company reported a net cash flow from financing activities of 995,856,243.57 yuan, compared to 792,284,207.26 yuan in the previous period, showing improved financing efficiency[56] Inventory and Other Assets - The ending balance of inventory increased by 71.34% to CNY 889.32 million, attributed to completed but unsettled construction contracts and increased consumable biological assets[20] - The ending balance of other current assets surged by 291.81% to CNY 119.51 million, primarily due to an increase in VAT input tax credits[20] - The ending balance of deferred tax assets grew by 52.39% to CNY 132.20 million, primarily due to increased provisions for bad debts on accounts receivable[21] - The ending balance of other receivables increased by 37.07% to CNY 146.94 million, mainly from increased bid and performance guarantees[20] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 69,457[12] - The largest shareholder, Wang Zhaoming, holds 23.87% of the shares, with 383,009,088 shares pledged[12] Corporate Actions and Future Plans - The company plans to issue convertible bonds with a total fundraising amount not exceeding 880 million RMB, which has been approved by the board[28] - The company plans to continue expanding its market presence and investing in new technologies, although specific figures were not disclosed in the report[44]